Matthew Robert Johnson

Title: Innovations by Matthew Robert Johnson

Introduction

Matthew Robert Johnson is an accomplished inventor based in Guilderland, NY. He holds three patents that reflect his significant contributions to the field of medical research and treatment. His work primarily focuses on developing compounds for various therapeutic applications.

Latest Patents

One of his latest patents is titled "Compounds for the treatment of spinal muscular atrophy and other uses." This patent describes compounds of Formula (I) or (II) that are useful for treating spinal muscular atrophy. It also outlines methods for using these compounds to increase SMN expression, enhance EAAT2 expression, or boost the expression of a nucleic acid that encodes a translational stop codon introduced by mutation or frameshift. Another notable patent is "Imidazole amines as inhibitors of β-secretase." This invention provides a compound of formula I and its use for the therapeutic treatment, prevention, or amelioration of diseases characterized by elevated β-amyloid deposits or levels in patients.

Career Highlights

Matthew has worked with prominent organizations such as Wyeth and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has significantly contributed to his expertise in the field of medical innovations.

Collaborations

Throughout his career, Matthew has collaborated with notable professionals, including Keith Douglas Barnes and Michael Sotirios Malamas. These collaborations have further enriched his research and development efforts.

Conclusion

Matthew Robert Johnson's innovative work in developing therapeutic compounds showcases his dedication to advancing medical science. His patents reflect a commitment to improving treatment options for various health conditions.